Page 276 - Read Online
P. 276

Liu et al.                                                                                                                                                                   Low antioxidant status of patients with CNSI

           Ethics approval                                    15.  Bahr NC, Boulware DR. Methods of rapid diagnosis for the etiology
           Data collection  in our study involving  the patient is   of meningitis in adults. Biomark Med 2014;8:1085-103.
           consistent with the ethical standards of the institution’s   16.  Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis,
                                                                 and treatment of neurocysticercosis. Lancet Neurol 2014;13:1202-15.
           ethics committee.                                  17.  Liu J, Li M, Wang X, Yi H, Xu L, Zhong XF, Peng FH. Serum uric
                                                                 acid levels in patients with infections of central nervous system. Acta
           REFERENCES                                            Neurol Belg 2016;116:303-8.
                                                              18.  Klein M, Koedel U, Pfister HW. Oxidative stress in pneumococcal
           1.   Nadal  D.  Progress  in  the  understanding  of  the  pathogenesis  and   meningitis:  a  future  target  for  adjunctive  therapy?  Prog  Neurobiol
               prevention  of  bacterial  otitis  media  and  meningitis.  Schweiz  Med   2006;80:269-80.
               Wochenschr 1999;129:2017-20. (in German)       19.  Kastenbauer S KU, Pfister HW. Role of peroxynitrite as a mediator
           2.   Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis   of  pathophysiological  alterations  in  experimental  pneumococcal
               Clin North Am 1999;13:527-48, v-vi.               meningitis. J Infect Dis 1999;180:1164-70.
           3.   Cheeseman KH, Slater TF. An introduction to free radical biochemistry.   20.  Kang DH, Ha SK. Uric acid puzzle: dual role as anti-oxidantand pro-
               Br Med Bull 1993;49:481-93.                       oxidant. Electrolyte Blood Press 2014;12:1-6.
           4.   Koedel U, Pfister HW. Oxidative stress in bacterial meningitis. Brain   21.  Fang P, Li X, Luo JJ, Wang H, Yang XF. A double-edged sword: uric
               Pathol 1999;9:57-67.                              acid and neurological disorders. Brain Disord Ther 2013;2:109.
           5.   Kurien  BT,  Scofield  RH.  Autoimmunity  and  oxidatively  modified   22.  Yan S, Zhang P, Xu W, Liu Y, Wang B, Jiang T, Hua C, Wang X,
               autoantigens. Autoimmun Rev 2008;7:567-73.        Xu D, Sun B. Serum uric acid increases risk of cancer incidence and
           6.   Hamed SA, Hamed EA, Zakary MM. Oxidative stress and S-100B   mortality: a systematic review and meta-analysis. Mediators Inflamm
               protein in children with bacterial meningitis. BMC Neurol 2009;9:51.  2015;2015:764250.
           7.   Gutteridge  JM,  Halliwell  B.  Free  radicals  and  antioxidants  in   23.  Jesus  S,  Perez  I,  Caceres-Redondo  MT,  Carrillo  F,  Carballo  M,
               the  year  2000. A  historical  look  to  the  future.  Ann  N  Y Acad  Sci   Gomez-Garre  P,  Mir  P.  Low  serum  uric  acid  concentration  in
               2000;899:136-47.                                  Parkinson’s disease in southern Spain. Eur J Neurol 2013;20:208-10.
           8.   Koprowski H, Spitsin SV, Hooper DC. Prospects for the treatment of   24.  Drulovic  J,  Dujmovic  I,  Stojsavljevic  N,  Mesaros  S,  Andjelkovic
               multiple sclerosis by raising serum levels of uric acid, a scavenger of   S,  Miljkovic  D,  Peric  V,  Dragutinovic  G,  Marinkovic  J,  Levic  Z,
               peroxynitrite. Ann Neurol 2001;49:139.            Mostarica Stojkovic M. Uric acid levels in sera from patients with
           9.   Toncev G, Milicic B, Toncev S, Samardzic G. Serum uric acid levels   multiple sclerosis. J Neurol 2001;248:121-6.
               in  multiple  sclerosis  patients  correlate  with  activity  of  disease  and   25.  Cuadrado A, Rojo AI. Heme oxygenase-1 as a therapeutic target in
               blood-brain barrier dysfunction. Eur J Neurol 2002;9:221-6.  neurodegenerative  diseases  and  brain  infections.  Curr  Pharm  Des
           10.  Becker  BF,  Kastenbauer  S,  Kodel  U,  Kiesl  D,  Pfister  HW.  Urate   2008;14:429-42.
               oxidation in CSF and blood of patients with inflammatory disorders   26.  Parfenova H, Leffler CW. Cerebroprotective functions of HO-2. Curr
               of  the  nervous  system.  Nucleosides  Nucleotides  Nucleic  Acids   Pharm Des 2008;14:443-53.
               2004;23:1201-4.                                27.  Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella
           11.  Stocker  R. Antioxidant  activities  of  bile  pigments.  Antioxid  Redox   D, Snyder SH. Bilirubin, formed by activation of heme oxygenase-2,
               Signal 2004;6:841-9.                              protects neurons against oxidative stress injury. Proc Natl Acad Sci U
           12.  Parfenova H, Leffler CW, Basuroy S, Liu J, Fedinec AL. Antioxidant   S A 1999;96:2445-50.
               roles  of  heme  oxygenase,  carbon  monoxide,  and  bilirubin  in   28.  Munoz-Sanchez   J,   Chanez-Cardenas   ME.  A   review   on
               cerebral  circulation  during  seizures.  J  Cereb  Blood  Flow  Metab   hemeoxygenase-2: focus on cellular protection and oxygen response.
               2012;32:1024-34.                                  Oxid Med Cell Longev 2014;2014:604981.
           13.  Bernardi M, Ricci CS, Zaccherini G. Role of human albumin in the   29.  Ward T, Powell RM, Evans DJ, Almond JW. Serum albumin inhibits
               management of complications of liver cirrhosis. J Clin Exp Hepatol   echovirus 7 uncoating. J Gen Virol 1999;80:283-90.
               2014;4:302-11.                                 30.  Guerrero AL, Martin-Polo J, Laherran E, Gutierrez F, Iglesias F, Tejero
           14.  Erel  O.  A  novel  automated  method  to  measure  total  antioxidant   MA, Rodriguez-Gallego M, Alcazar C. Variation of serum uric acid
               response  against  potent  free  radical  reactions.  Clin  Biochem   levels in multiple sclerosis during relapses and immunomodulatory
               2004;37:112-9.                                    treatment. Eur J Neurol 2008;15:394-7.























                           Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ December 15, 2016           267
   271   272   273   274   275   276   277   278   279   280   281